Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MDG1011 |
Trade Name | |
Synonyms | MDG 1011|MDG-1011 |
Drug Descriptions |
MDG1011 is T lymphocytes engineered to express preferentially expressed antigen in melanoma (PRAME)-specific TCR coupled to the CD3 signaling complex, which may induce death of PRAME-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C156136 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MDG1011 | MDG1011 | 0 | 1 |